Immune regulation and cell metabolism in B cell subsets in patients with systemic lupus erythematosus - Takeaways - MDSpire

Immune regulation and cell metabolism in B cell subsets in patients with systemic lupus erythematosus

  • By

  • Masanobu Ueno

  • Satoshi Kubo

  • Yasuyuki Todoroki

  • Shingo Nakayamada

  • Yoshiya Tanaka

  • May 26, 2026

Share

  • 1

    Systemic lupus erythematosus (SLE) is an autoimmune disease primarily affecting young women and involving multiple organ systems.

  • 2

    Autoreactive B cells play a crucial role in SLE by mediating antibody production, antigen presentation, and cytokine secretion.

  • 3

    Immunometabolism is a key regulatory mechanism influencing B cell activation, differentiation, and the pathogenesis of SLE.

  • 4

    Disruption of B-cell tolerance mechanisms in SLE leads to increased autoreactive B cells and excessive autoantibody production.

  • 5

    Recent advancements in B-cell targeted therapies, such as belimumab and rituximab, show promise in managing SLE and reducing glucocorticoid dependence.

Original Source(s)

Immune regulation and cell metabolism in B cell subsets in patients with systemic lupus erythematosus

  • by Masanobu Ueno, Satoshi Kubo, Yasuyuki Todoroki, Shingo Nakayamada, Yoshiya Tanaka

  • May 26, 2026

Related Content

RA Outcomes Improved in KURAMA Cohort

Ten-year observational data showed lower disease activity and functional disability coinciding with broader use of biologic and targeted synthetic therapies.

JAK Monotherapy Shows Efficacy in RA Review

A systematic review found Janus kinase inhibitor monotherapy improved outcomes vs methotrexate or placebo, but direct comparisons with combination therapy were limited.

FDA Clears Golimumab Biosimilars

New biosimilars enter the market with pharmacy-level substitution eligibility for rheumatology and gastroenterology indications.